- Clinical Experience
- Rheumatology
- Pulmonology
- Ophthalmology
- Nephrology
- Neurology
- Proposed MOA
- Dosing & Duration
- Safety Data
- Acthar Patient Support
- Resources & Videos
Acthar Patient Support is available. Learn more.
Case study provided by: Kostas Botsoglou, MD, MPH - Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York
This case study is provided for general medical education purposes only and is not a substitute for independent clinical medical judgment. The intent of this case study is to present the experience of an individual patient, which may not represent outcomes in the overall patient population. Response to treatment may vary from patient to patient.
Woman, aged 32 years, with a 5-year history of SLE, experiencing recurring disease activity and intolerance to current treatment
Treatment history1
C3=component 3; C4=component 4; dsDNA=double-stranded DNA; ESR=erythrocyte sedimentation rate; HCT=hematocrit; Hgb=hemoglobin; WBC=white blood cells.
*MMF is not FDA-approved to treat SLE.2
Clinical outcomes may not be solely attributable to Acthar Gel.
Dosage should be individualized according to the medical condition of each patient. Frequency and dose of the drug should be determined by considering the severity of the disease and the initial response of the patient.
Sudden withdrawal of Acthar Gel after prolonged use may lead to adrenal insufficiency or recurrent symptoms. It may be necessary to taper the dose and increase the injection interval to gradually discontinue the medication.
Is this case study relevant to your practice?
Download a copy now to keep for your reference.
Start the referral process for your appropriate patients
Acthar® Gel is indicated for:
Contraindications
Acthar is contraindicated:
Warnings and Precautions
Adverse Reactions
Pregnancy
Please see full Prescribing Information for additional Important Safety Information.
References:
References:
References:
References:
References:
References:
References:
References:
References:
References:
References:
References:
References:
References:
References:
References:
References:
References:
References:
References:
References:
References:
References:
References:
References:
References:
References:
References:
References:
References:
References:
References:
References:
References:
References:
References:
References: